Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The PERSEVERE Study

NCT: NCT06588634 · RECRUITING

NCT IDNCT06588634
StatusRECRUITING
Start Date2024-12-16
Completion2028-02

Brief Summary

Randomized Controlled Trial of High-Risk Pulmonary Embolism Comparing FlowTriever System vs. Standard of Care

Frequently Asked Questions

What is The PERSEVERE Study?

The PERSEVERE Study is a clinical trial registered under NCT06588634. Current status: RECRUITING.

What is the status of NCT06588634?

The current status of NCT06588634 (The PERSEVERE Study) is: RECRUITING.

When did The PERSEVERE Study start?

The PERSEVERE Study started on 2024-12-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.